BioSpace News Archive

GE HealthCare, a leading medical technology innovator, announced its largest ever CT deal in the United States – a $30 million order by St. Luke’s University Health Network, a nationally recognized nonprofit healthcare network, to install 21 of GE HealthCare’s innovative CT systems, powered by Artificial Intelligence, across their system.

Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies’ (NASDAQ:BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in New Orleans, LA, last week.

Indivior PLC announced that it will participate in the following investor events:

Propanc Biopharma, Inc., a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced that the Company’s intellectual property portfolio made important advancements in Europe.

Hepagene Therapeutics, Inc. today announced that Hepagene will present two posters highlighting the preclinical and clinical development for its two non-alcoholic steatohepatitis (NASH) programs at the European Association for the Study of the Liver (EASL) Congress, taking place in Vienna Austria, June 21-24, 2023.

Brain Cancer Canada, a leading charity in the fight against brain cancer, is delighted to announce a $50,000 research grant to Dr. Amit Singnurkar at Sunnybrook Health Sciences Centre.

Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced that it received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC on May 23, 2023 indicating that the Company is not currently in compliance with Nasdaq’s Listing Rules due to the Company’s inability to timely file its Form 10-Q for the three months ended March 31, 2023 with the Securities and Exchange Commission.

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced that it will be participating in the following upcoming investor conferences.

Gilead Sciences, Inc. announced that its executives will be speaking at the following investor conference: Jefferies Healthcare Conference on Wednesday, June 7 at 11:00am ET The live webcast can be accessed at the company’s investors page at investors.gilead.com.

Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced that Carmine Stengone, CEO of Pipeline, will present on June 9, 2023 at 12:15pm ET at the 2023 Jefferies Global Healthcare Conference, being held June 7-9, 2023 in New York, NY.